Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model

The use of antibody-based therapies for the treatment of high consequence viral pathogens has gained interest over the last fifteen years. Here, we sought to evaluate the use of unique camelid-based IgG antibodies to prevent lethal hantavirus pulmonary syndrome (HPS) in Syrian hamsters. Using purifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sroga, Patrycja, Sloan, Angela, Warner, Bryce M., Tierney, Kevin, Lew, Jocelyne, Liu, Guodong, Chan, Michael, Deschambault, Yvon, Stein, Derek R., Soule, Geoff, Banadyga, Logan, Falzarano, Darryl, Safronetz, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408274/
https://www.ncbi.nlm.nih.gov/pubmed/34465819
http://dx.doi.org/10.1038/s41598-021-96884-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408274/
https://www.ncbi.nlm.nih.gov/pubmed/34465819
http://dx.doi.org/10.1038/s41598-021-96884-6

Ejemplares similares